Press Releases

Augurex Announces Agreement With ARUP To Expand Access to Advanced Rheumatoid Arthritis Diagnosis

ARUP Laboratories is partnering with Augurex Life Sciences Corp. to include the 14-3-3η test in the ARUP test menu to enhance the early detection of rheumatoid arthritis.

ARUP Awarded CDC Contract for Bird Flu Test Development

ARUP has been awarded a CDC contract for avian influenza A (H5N1) test development, which recognizes our expertise and experience with assay development and our desire to serve public health needs.

New ARUP Laboratories’ Grant Will Fund Innovative Research to Advance Laboratory Medicine

The new Sherrie Perkins Research and Innovation Collaboration Grant, designed to foster collaboration in healthcare, will fund cutting-edge research in lab medicine that could impact patient care.

ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests

ARUP’s declaration amplifies the lawsuit’s claims that the FDA does not have legal authority over laboratory testing services and that regulating these services is unreasonable.

ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices

ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.

ARUP Partners With ELLKAY to Bring Connectivity Solutions to Health System Outreach Operations

A new partnership between ARUP and connectivity provider ELLKAY aims to give health systems the testing support, guidance, and technology needed to establish or expand lab outreach operations.

New ARUP University Business Unit Focuses on Patients and Services at University of Utah Health

Dan Albertson, MD, will serve as president of the new University Business Unit and become a member of ARUP’s executive committee. Albertson said service to patients and colleagues will be his focus.

Lab Community “Extremely Concerned” About Patient Access to Testing If FDA Regulates Lab-Developed Tests

Nearly 85% of respondents to an ARUP survey believe the FDA’s proposed rule to regulate lab-developed tests will negatively impact their labs. Only 3% believe they have the financial resources to comply.

ARUP’s Julio Delgado, MD, MS, Selected as Inaugural Harry R. Hill, MD, Presidential Endowed Chair-Holder

ARUP and the University of Utah Department of Pathology have announced that ARUP’s executive vice president, Julio Delgado, MD, MS, will be the inaugural holder of a new presidential endowed chair.

Partnership Between ARUP and Medicover Expands Access to Companion Diagnostic in the European Union

ARUP and Medicover have partnered to provide a new companion diagnostic test to European Union patients. The test helps identify individuals eligible for a new gene therapy for severe hemophilia A.

ARUP Laboratories Honored With 2023 Best Companies to Work For Award From Utah Business Magazine

Utah Business magazine honored ARUP Laboratories with its Best Companies to Work For award for the sixth consecutive year based on anonymous employee survey results.

ARUP Laboratories Urges FDA to Withdraw Proposed Rule Regulating Laboratory-Developed Tests

ARUP believes the FDA’s plan to regulate lab-developed tests will limit access to testing, increase costs, and face a court challenge, and is calling for collaboration to better address LDT oversight.